# Oral Dosage Form New Animal Drugs; Enrofloxacin Tablets
> **Food and Drug Administration** · Final rule. · Published 1999-09-03 · Effective 1999-09-03 · 64 FR 48295
## Document
- **Document number:** 99-22998
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 48295
- **CFR reference:** 21 CFR 520
- **Publication date:** 1999-09-03
- **Effective date:** 1999-09-03
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer Corp., Agriculture Division, Animal Health. The supplemental NADA provides for an additional tablet size for enrofloxacin tablets used in dogs and cats for the management of diseases associated with bacteria susceptible to enrofloxacin and for the removal of a tablet size no longer marketed.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/09/03/99-22998/oral-dosage-form-new-animal-drugs-enrofloxacin-tablets)
---
*AI Analytics · CC0 1.0*